These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2144486)
1. Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Mariani E; Roda P; Mariani AR; Vitale M; Degrassi A; Papa S; Facchini A Clin Exp Immunol; 1990 Sep; 81(3):479-84. PubMed ID: 2144486 [TBL] [Abstract][Full Text] [Related]
2. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. Moretta A; Tambussi G; Bottino C; Tripodi G; Merli A; Ciccone E; Pantaleo G; Moretta L J Exp Med; 1990 Mar; 171(3):695-714. PubMed ID: 2137855 [TBL] [Abstract][Full Text] [Related]
3. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus. Hori T; Spits H J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017 [TBL] [Abstract][Full Text] [Related]
4. Human cytotoxic lymphocytes. IV. Frequency and clonal specificity of CD8+CD16-(Leu2+Leu11-) and CD16+CD3-(Leu11+Leu4-) cytotoxic lymphocyte precursors activated by alloantigen or K562 stimulator cells. Kabelitz D Cell Immunol; 1989 Jul; 121(2):298-305. PubMed ID: 2525425 [TBL] [Abstract][Full Text] [Related]
5. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder. Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700 [TBL] [Abstract][Full Text] [Related]
6. In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. Mingari MC; Poggi A; Biassoni R; Bellomo R; Ciccone E; Pella N; Morelli L; Verdiani S; Moretta A; Moretta L J Exp Med; 1991 Jul; 174(1):21-6. PubMed ID: 1711562 [TBL] [Abstract][Full Text] [Related]
7. Thymic origin of some natural killer cells: clonal proliferation of human CD3-16+ cells from CD3-4-8- thymocyte precursors requires the presence of H9 leukemic cells. Mingari MC; Poggi A; Bellomo R; Pella N; Moretta L Int J Clin Lab Res; 1991; 21(2):176-8. PubMed ID: 1840028 [TBL] [Abstract][Full Text] [Related]
8. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1. van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018 [TBL] [Abstract][Full Text] [Related]
9. Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: numerous CD8- and CD16-positive cells in the tumor. Lakhdar M; Ben Aribia MH; Maalej M; Ladgham A Int J Cancer; 1991 Apr; 48(1):57-61. PubMed ID: 1826899 [TBL] [Abstract][Full Text] [Related]
10. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946 [TBL] [Abstract][Full Text] [Related]
11. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808 [TBL] [Abstract][Full Text] [Related]
12. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset. Mansour I; Doinel C; Rouger P AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319 [TBL] [Abstract][Full Text] [Related]
16. Morphometric evaluation of CD16-positive cells with respect to CD2 antigen coexpression. Manara GC; Ferrari C; Pagani L; Sansoni P; Bologna G; Molinari A; Torresani C; De Panfilis G Cell Immunol; 1990 Jun; 128(1):118-29. PubMed ID: 1971527 [TBL] [Abstract][Full Text] [Related]
17. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria. Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415 [TBL] [Abstract][Full Text] [Related]
18. Activation of cloned human natural killer cells via Fc gamma RIII. Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637 [TBL] [Abstract][Full Text] [Related]
19. Both CD8+ and CD16+ human T cell clones can provide B cell help for immunoglobulin production. Simonelli C; Rugiu FS; Manetti R; Parronchi P; Piccinni MP; Almerigogna F; Romagnani S; Maggi E Int J Clin Lab Res; 1992; 22(1):36-9. PubMed ID: 1385990 [TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity in monoclonal gammopathies: relation to disease activity. Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]